An Educational Resource by
Women's Cancer Initiative - Tata Memorial Hospital
Day 2, 27th April 2019
Rightsizing Surgical Options : Upfront and Post Neoadjuvant
Moderator : Vani Parmar
Consensus to Clinic : Surgery
Speaker : Ramesh Sarin
Consensus Panel on Individualising Radiotherapy - Post Breast Conserving Surgery, Mastectomy, Primary Systemic Therapy and Reconstruction
Moderator : Anusheel Munshi
Consensus to Clinic : Radiation
Speaker : Tabassum Wadasadawala
Proton Therapy in Breast Cancer
Speaker : Rakesh Jalali
Consensus Panel on HR+ve Breast Cancer : Risk Stratification and Making Right Choice
Moderator : B. K Smruti
CDK 4/6 Inhibitor : Whats New and What’s Left to Learn?
Speaker : Tiffany Traina
Case Based Panel Discussion
Moderator : T. Raja
Consensus Panel on Optimising Chemotherapy
Moderator : T. P Sahoo
Consensus to Clinic : Chemotherapy
Speaker : Bharath Rangarajan
Consensus Panel on Neoadjuvant Therapies : Breast Cancer Subtypes and Specific Strategies
Moderator : R. Ranga Rao
Consensus to Clinic : Neoadjuvant Therapy
Speaker : Ashish Singh
Debate : Are Clinico-Pathologic Online Tools ; A Valid Alternative to Genomic Profile
Speaker : Sudeep Gupta & Senthil Rajappa
Does Hormone Receptor Status Impact Biology and Therapy in HER2+ve Breast Cancer?
Speaker : Pierfranco Conte
Consensus on HER2 Breast Cancer : To Ease or To Intensify
Speaker : Manish Singhal
Defining and Treating a New Segment in Breast Cancer - gBRCA+ve HER-ve MBC
Speaker : Vashishth Maniar
Case Based Panel Discussion on gBRCA+ve HER-ve MBC
Moderator : Manish Singhal
Consensus on Specific Issues
Moderator : Chanchal Goswami
Indian Experience of Eribulin
Speaker : Shailesh Bondarde
HER2+ve Breast Cancer - Indian Perspective
Speaker : Sudeep Gupta
HER2+ve Metastatic Breast Cancer: A Chronic Disease?
Speaker : Senthil Rajappa
HER2+ve Breast Cancer – Evolving Story
Speaker : Pierfranco Conte
Adjuvant Therapy – Escalating & De-escalating – What is the Future?
Speaker : Helena Earl
HER2+ve Breast Cancer and Pregnancy
Speaker : Matteo Lambertini
Brain Mets in Patients with HER2+ve Breast Cancer
Speaker : Amit Agarwal